Blood Platelets Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| CAGR | 3.00 % |
| Fastest Growing Market | Asia-Pacific |
| Largest Market | North America |
| Market Concentration | Medium |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
Blood Platelets Market Analysis
The blood platelets market is projected to register a CAGR of 3% during the forecast period.
The COVID-19 pandemic was an unprecedented health concern that impacted the blood platelets market. During the COVID-19 epidemic, there was an international shortage of blood donors since most donors were afraid of contracting the infection. For instance, according to the American Red Cross in January 2022, since the start of the pandemic, the Red Cross has seen a 10% drop in the number of people donating blood, and the organization has dealt with pandemic-related concerns such as ongoing blood drives cancellations and personnel shortages. The increase in COVID-19 cases adds to the concern. The Red Cross had seen low donor turnout during the pandemic. Thus, a decline in blood donation and the cancellation of blood donation drives during the pandemic severely impacted the market growth during the COVID era. Nevertheless, since the limits were removed, the sector has been recovering strongly. The market recovery over the following years has been driven by an increase in blood donation drives and a decline in COVID-19 infection apprehension.
Market growth can be largely attributed to factors such as the increasing prevalence of chronic blood-related disorders and the rising number of surgical procedures. These factors have created significant demand for blood platelets over the years and may continue to do so in the future.
With the increasing prevalence of chronic blood-related disorders, such as myelofibrosis, leukemia, hemophilia, and thrombocytopenia, there is an increased demand for blood platelets. According to the World Federation of Hemophilia's October 2021 report, owing to the sex linkage of the disorder, there is a higher prevalence of hemophilia in males than in females. Hemophilia occurs worldwide and across all racial groups. According to the World Federation of Hemophilia global report published in October 2021, there were 209,614 people diagnosed with hemophilia. These included 165,379 Hemophilia A patients, 33,076 Hemophilia B patients, and 11,159 Hemophilia type unknown patients. Such a huge prevalence of hemophilia will lead to increased adoption of therapies for hemophilia, driving the market growth. Leukemia affects a considerable proportion of the world's population.
According to GLOBOCAN 2020 statistics, leukemia accounted for 474,519 cases for both sexes and all ages globally in 2020. Furthermore, according to the Leukemia & Lymphoma Society's 2021 statistics, an estimated 397,501 persons in the United States are living with or in remission from leukemia. As a result, overall statistics show that many people are at risk of developing leukemia, which may directly impact market growth during the projection period.
The increasing number of surgical procedures worldwide contributes to the increasing demand for blood platelets. Similarly, an increase in the number of orthopedic and cardiac surgeries contributes to the rising demand for blood platelets in hospitals. Additionally, an increase in organ transplantations has boosted the demand for blood platelets. As per the data published by the Health Resources and Services Administration in March 2022, about 40,000 organ transplants were performed in the United States in 2021. In addition, 26,670 kidney transplants and 9,236 liver transplants were performed in the United States in 2021. Moreover, an increase in the number of trauma surgeries due to impact forces, such as accidents, falls, sports, and crush injuries, is projected to boost the demand for blood platelets in the coming years. For instance, according to 2021 statistics by the World Health Organization, 20-50 million people suffer from non-fatal road injuries each year. Such a huge number indicates these populations' rising need for blood platelets.
Thus, all the above-mentioned factors are currently augmenting the growth of the blood platelets market. However, the shortage of blood donors, the risk of infections, and the high cost of surgeries are a few factors that restrain the market growth.
Blood Platelets Market Trends
This section covers the major market trends shaping the Blood Platelets Market according to our research experts:
Platelet Function Disorders Segment is Expected to Witness a Significant CAGR During the Forecast Period
Based on applications, platelet function disorders are predicted to witness significant growth. The major factors owing to the growth of the segment are the increasing prevalence of cancer. Chronic myelogenous leukemia and multiple myeloma cancers lead to the development of acquired platelet function disorders in some cancer patients. Therefore, cancer patients must undergo platelet transfusions frequently. For instance, the American Cancer Society predicted in 2022 that approximately 34,470 people were likely to be diagnosed with multiple myeloma in the United States. Such numbers indicate the rising demand for platelet transfusions in the treatment of cancer patients. Moreover, chronic platelet function disorders contribute to the increasing demand for platelet transfusions. Thus, the administration of platelets in such patients is frequently performed to mitigate complications, including RBC requirements, surgical blood loss, and reoperation for bleeding.
Growing R&D activity by research institutes is also expected to support market growth. For instance, in March 2021, Dr. Bethan Psaila, Group Leader at the Medical Research Council Molecular Haematology Unit (MRC MHU) and principal investigator at the Radcliffe Department of Medicine at Oxford University and Cancer Research UK (CRUK) Advanced Clinician Scientist looked into the possibility of circulating blood platelets for early diagnosis of various cancer types. Thus, such R&D activity is expected to bring advanced blood platelet products into the market, and it is likely to support the growth of the segment during the forecast period.
Thus, due to the above-mentioned factors, the segment is anticipated to grow significantly during the forecast period.
North America is Expected to Hold a Significant Share in the Market and Expected to do Same Over the Forecast Period.
North America is expected to show a similar trend during the forecast period without significant fluctuations. This is largely due to the presence of several organizations engaged in the distribution of blood components. Moreover, the organizations in the region are engaged in increasing awareness regarding the importance of blood donation, which is increasing the number of blood donors in the region. For instance, according to the American Red Cross in January 2022, an estimated 6.8 million people in the United States donate blood each year. In the United States, 13.6 million units of whole blood and red blood cells are collected each year.
Additionally, the number of platelet transfusions in the region has boosted the demand for blood platelets. For instance, as per January 2022 statistics by The American National Red Cross, approximately 16 million blood components are transfused each year in the United States. Thus, due to the above-mentioned factors, the blood platelets market is anticipated to grow significantly during the forecast period in North America. Moreover, the growing prevalence of blood-related diseases is expected to boost market growth. According to the World Federation of Hemophilia 2021 report, there were 14,816 patients with hemophilia in the United States in 2020, including (Hemophilia A -11,790 and Hemophilia B-3,026) and people diagnosed with hemophilia in the United States, and 3,924 patients with hemophilia in Canada in 2020, including Hemophilia A -3,223 and Hemophilia B-701. Thus, the increasing prevalence of hemophilia is likely to support the growth of the market.
In addition, strategic activity by the key market players is expected to boost market growth. For instance, in May 2021, Canadian Blood Services entered a contract with Cercus Corporation for the INTERCEPT Blood System for platelets.
Thus, all the aforementioned factors are expected to boost the market in the region.
Blood Platelets Industry Overview
The blood platelets market is moderately competitive, and a few companies currently dominate the market. These companies include Blood Centers of America, the American National Red Cross, Canadian Blood Services, Cellphire Inc., and PlateletBio, among others. The competition in the market is majorly based on the provision of blood components by these companies. Additionally, key players have been involved in organizing blood donation drives, campaigns, and blood supply services to meet the demand from ambulatory surgical centers and hospitals. In order to secure its position in the global market, the focus has been on expanding the collection of blood platelets.
Blood Platelets Market Leaders
The American National Red Cross
Blood Centers of America
Canadian Blood Services
The European Blood Alliance
Australian Red Cross
*Disclaimer: Major Players sorted in no particular order
Blood Platelets Market News
- July 2022: The University of Cincinnati's Hoxworth Blood Center launched its "10 Days of Platelets" campaign to address the severe need for platelet donors.
- January 2022: Canadian Blood Services launched its first pathogen-reduced fresh blood product. Pathogen-reduced platelets are now on the shelves of hospitals served by Ottawa production sites.
Blood Platelets Market Report - Table of Contents
1. INTRODUCTION
1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Number of Surgical Procedures
4.2.2 Increasing Prevalence of Chronic and Blood-related Disorders
4.3 Market Restraints
4.3.1 High Cost and Risk of Infections in Transfusion Procedure
4.3.2 Shortage of Blood Donors
4.4 Industry Attractiveness - Porter's Five Forces Analysis
4.4.1 Bargaining Power of Buyers/Consumers
4.4.2 Bargaining Power of Suppliers
4.4.3 Threat of New Entrants
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Applications
5.1.1 Platelet Function Disorders
5.1.2 Hemophilia
5.1.3 Thrombocytopenia
5.1.4 Perioperative Indications
5.2 By End User
5.2.1 Hospitals
5.2.2 Ambulatory Surgical Centers
5.2.3 Other End Users
5.3 Geography
5.3.1 North America
5.3.1.1 United States
5.3.1.2 Canada
5.3.1.3 Mexico
5.3.2 Europe
5.3.2.1 Germany
5.3.2.2 United Kingdom
5.3.2.3 France
5.3.2.4 Italy
5.3.2.5 Spain
5.3.2.6 Rest of Europe
5.3.3 Asia-Pacific
5.3.3.1 China
5.3.3.2 Japan
5.3.3.3 India
5.3.3.4 Australia
5.3.3.5 South Korea
5.3.3.6 Rest of Asia-Pacific
5.3.4 Middle East and Africa
5.3.4.1 GCC
5.3.4.2 South Africa
5.3.4.3 Rest of Middle East and Africa
5.3.5 South America
5.3.5.1 Brazil
5.3.5.2 Argentina
5.3.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 America's Blood Centers
6.1.2 Blood Centers of America
6.1.3 American Association of Blood Banks (AABB)
6.1.4 American National Red Cross
6.1.5 Canadian Blood Services
6.1.6 The European Blood Alliance
6.1.7 OneBlood
6.1.8 Blood Bank of Alaska
6.1.9 Australian Red Cross
6.1.10 Brazilian Red Cross
6.1.11 French Red Cross
6.1.12 Indian Red Cross Society
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
Blood Platelets Industry Segmentation
Platelets are the components of blood essential for clotting. Low platelet counts result in bleeding. Platelets stop bleeding mainly by clumping and forming plugs in blood vessels that have been injured.
The blood platelets market is segmented by application (platelet function disorders, hemophilia, thrombocytopenia, and perioperative indications), end user (hospitals, ambulatory surgical centers, and other end users), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America). The market report also covers estimated market sizes and trends for 17 different countries across major regions globally. The report offers the value (in USD million) for the above segments.
| By Applications | |
| Platelet Function Disorders | |
| Hemophilia | |
| Thrombocytopenia | |
| Perioperative Indications |
| By End User | |
| Hospitals | |
| Ambulatory Surgical Centers | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Blood Platelets Market Research FAQs
What is the current Blood Platelets Market size?
The Blood Platelets Market is projected to register a CAGR of 3% during the forecast period (2024-2029)
Who are the key players in Blood Platelets Market?
The American National Red Cross, Blood Centers of America, Canadian Blood Services, The European Blood Alliance and Australian Red Cross are the major companies operating in the Blood Platelets Market.
Which is the fastest growing region in Blood Platelets Market?
Asia-Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Blood Platelets Market?
In 2024, the North America accounts for the largest market share in Blood Platelets Market.
What years does this Blood Platelets Market cover?
The report covers the Blood Platelets Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Blood Platelets Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Blood Platelets Industry Report
Statistics for the 2024 Blood Platelets market share, size and revenue growth rate, created by Mordor Intelligenceā¢ Industry Reports. Blood Platelets analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
